sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > Others > Signaling pathway-Others > BTZ043
BTZ043  
Catalog No. T3582    CAS 1161233-85-7
Pack Size
Availability
Price/USD
Quantity
5mg
In stock
77.00
10mg
In stock
136.00
25mg
In stock
267.00
50mg
In stock
493.00
100mg
In stock
748.00
1g
Get quote
0.00
5g
Get quote
0.00
10mM * 1mL (in DMSO)
In stock
84.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.97% COA Datasheet HNMR HPLC
Biological Activity:

Product Description:

BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.

Target:
DprE1;
Research Area:
Respiratory system/ Immunology system
Chemical Information:
Molecular Weight 431.39
Formula C17H16F3N3O5S
CAS Number 1161233-85-7
Solubility DMSO:13.3 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
  • The compound is not included in our libraries at this moment.
Product Recommendations
  • Batefenterol, Batefenterol (GSK961081, TD-5959) is a muscarinic receptor antagonist and β2-adrenoceptor agonist. I...
  • GLPG1690, GLPG-1690, an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in idio...
  • PBTZ169 , PBTZ169 inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
  • GAL-021, GAL-021 an intravenous BKCa-channel blocker.
  • NIH-12848, NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an I...

 

Reference

If you have additional questions, Please send us a message. * Required